Anacetrapib reduces risk of serious cardiovascular events in high risk patients on statins
Anacetrapib, an inhibitor of cholesteryl ester transfer protein (CETP) activity, lowers the risk of heart attack and related cardiovascular complications in patients receiving intensive statin treatment, according to late-breaking ...
Aug 29, 2017
0
0